A detailed history of Virginia Retirement Systems Et Al transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Virginia Retirement Systems Et Al holds 16,742 shares of NTLA stock, worth $211,284. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,742
Previous 17,742 5.64%
Holding current value
$211,284
Previous $166,000 74.1%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 20, 2025

SELL
$9.88 - $17.76 $9,880 - $17,760
-1,000 Reduced 5.64%
16,742 $289,000
Q2 2025

Jul 29, 2025

BUY
$6.28 - $9.67 $5,652 - $8,703
900 Added 5.34%
17,742 $166,000
Q1 2025

Jul 16, 2025

BUY
$7.11 - $12.8 $119,746 - $215,577
16,842 New
16,842 $119,000
Q2 2023

Aug 22, 2023

BUY
$34.58 - $46.03 $58,786 - $78,251
1,700 Added 24.64%
8,600 $350,000
Q1 2023

Jul 11, 2023

BUY
$33.3 - $44.82 $229,769 - $309,258
6,900 New
6,900 $257,000
Q1 2022

Apr 21, 2022

SELL
$58.27 - $118.99 $244,734 - $499,758
-4,200 Closed
0 $0
Q4 2021

Feb 03, 2022

SELL
$100.76 - $138.36 $483,648 - $664,128
-4,800 Reduced 53.33%
4,200 $497,000
Q3 2021

Oct 21, 2021

SELL
$132.37 - $176.78 $132,370 - $176,780
-1,000 Reduced 10.0%
9,000 $1.21 Million
Q2 2021

Aug 13, 2021

SELL
$60.88 - $161.91 $91,320 - $242,865
-1,500 Reduced 13.04%
10,000 $1.62 Million
Q1 2021

Apr 30, 2021

BUY
$46.59 - $83.68 $93,180 - $167,360
2,000 Added 21.05%
11,500 $923,000
Q4 2020

Feb 16, 2021

BUY
$18.83 - $63.53 $178,884 - $603,535
9,500 New
9,500 $517,000

Others Institutions Holding NTLA

About Intellia Therapeutics, Inc.


  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $959M
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track Virginia Retirement Systems Et Al Portfolio

Follow Virginia Retirement Systems Et Al and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Virginia Retirement Systems Et Al with notifications on news.